{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:47:35Z","timestamp":1790938055401,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG062677"],"award-info":[{"award-number":["P30 AG062677"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG006786"],"award-info":[{"award-number":["U01 AG006786"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG006786"],"award-info":[{"award-number":["U01 AG006786"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG062677"],"award-info":[{"award-number":["P30 AG062677"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG006786"],"award-info":[{"award-number":["U01 AG006786"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG069052"],"award-info":[{"award-number":["RF1 AG069052"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00789-3","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:53:52Z","timestamp":1772700832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma biomarkers of Alzheimer\u2019s disease and their association with disproportionately enlarged subarachnoid space hydrocephalus"],"prefix":"10.1186","volume":"23","author":[{"given":"Camilo","family":"Bermudez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Hofrenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Fought","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrice M.","family":"Cogswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill R.","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"3","key":"789_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024;81(3):255\u201363.","journal-title":"JAMA Neurol"},{"issue":"4","key":"789_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"key":"789_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.025","volume":"44","author":"SJB Vos","year":"2016","unstructured":"Vos SJB, Gordon BA, Su Y, Visser PJ, Holtzman DM, Morris JC, et al. NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Neurobiol Aging. 2016;44:1\u20138.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"789_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","volume":"116","author":"A Agren-Wilsson","year":"2007","unstructured":"Agren-Wilsson A, Lekman A, Sjoberg W, Rosengren L, Blennow K, Bergenheim AT, et al. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand. 2007;116(5):333\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"15","key":"789_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","volume":"80","author":"A Jeppsson","year":"2013","unstructured":"Jeppsson A, Zetterberg H, Blennow K, Wikkelso C. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. Neurology. 2013;80(15):1385\u201392.","journal-title":"Neurology"},{"issue":"22","key":"789_CR6","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1056\/NEJMoa2503109","volume":"393","author":"MG Luciano","year":"2025","unstructured":"Luciano MG, Williams MA, Hamilton MG, Katzen HL, Dasher NA, Moghekar A, et al. A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus. N Engl J Med. 2025;393(22):2198\u2013209.","journal-title":"N Engl J Med"},{"issue":"8","key":"789_CR7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.mayocp.2023.12.024","volume":"99","author":"W Li","year":"2024","unstructured":"Li W, Petersen RC, Algeciras-Schimnich A, Cogswell PM, Bornhorst JA, Kremers WK, et al. Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice. Mayo Clin Proc. 2024;99(8):1284\u201396.","journal-title":"Mayo Clin Proc"},{"issue":"17","key":"789_CR8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1212\/WNL.0000000000000916","volume":"83","author":"NR Graff-Radford","year":"2014","unstructured":"Graff-Radford NR. Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology. 2014;83(17):1573\u20135.","journal-title":"Neurology"},{"key":"789_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1743-8454-7-18","volume":"7","author":"M Hashimoto","year":"2010","unstructured":"Hashimoto M, Ishikawa M, Mori E, Kuwana N. Study of Ioni. Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res. 2010;7:18.","journal-title":"Cerebrospinal Fluid Res"},{"issue":"24","key":"789_CR10","doi-asserted-by":"publisher","first-page":"e2237","DOI":"10.1212\/WNL.0000000000008616","volume":"93","author":"J Graff-Radford","year":"2019","unstructured":"Graff-Radford J, Gunter JL, Jones DT, Przybelski SA, Schwarz CG, Huston J, et al. Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition. Neurology. 2019;93(24):e2237\u201346. 3rd.","journal-title":"Neurology"},{"key":"789_CR11","doi-asserted-by":"publisher","first-page":"101605","DOI":"10.1016\/j.nicl.2018.11.015","volume":"21","author":"NB Gunter","year":"2019","unstructured":"Gunter NB, Schwarz CG, Graff-Radford J, Gunter JL, Jones DT, Graff-Radford NR, et al. Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods. Neuroimage Clin. 2019;21:101605.","journal-title":"Neuroimage Clin"},{"key":"789_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2021.10.017","volume":"110","author":"J Graff-Radford","year":"2022","unstructured":"Graff-Radford J, Jones DT, Wiste HJ, Cogswell PM, Weigand SD, Lowe V, et al. Cerebrospinal fluid dynamics and discordant amyloid biomarkers. Neurobiol Aging. 2022;110:27\u201336.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"789_CR13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/alz.12466","volume":"18","author":"JA Syrjanen","year":"2022","unstructured":"Syrjanen JA, Campbell MR, Algeciras-Schimnich A, Vemuri P, Graff\u2010Radford J, Machulda MM, et al. Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities. Alzheimer\u2019s Dement. 2022;18(6):1128\u201340.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"789_CR14","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/alz.12787","volume":"19","author":"A Pichet Binette","year":"2023","unstructured":"Pichet Binette A, Janelidze S, Cullen N, Dage JL, Bateman RJ, Zetterberg H, et al. Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance. Alzheimers Dement. 2023;19(4):1403\u201314.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"789_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-023-02594-w","volume":"146","author":"C Bermudez","year":"2023","unstructured":"Bermudez C, Graff-Radford J, Syrjanen JA, Stricker NH, Algeciras-Schimnich A, Kouri N, et al. Plasma biomarkers for prediction of Alzheimer\u2019s disease neuropathologic change. Acta Neuropathol. 2023;146(1):13\u201329.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"789_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183\u201394.","journal-title":"J Intern Med"},{"key":"789_CR17","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, Association D. AP. Diagnostic and statistical manual of mental disorders: DSM-5. American psychiatric association Washington, DC; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"5","key":"789_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.25071","volume":"82","author":"P Vemuri","year":"2017","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J, et al. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. Ann Neurol. 2017;82(5):706\u201318.","journal-title":"Ann Neurol"},{"issue":"4","key":"789_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","volume":"30","author":"NR Barthelemy","year":"2024","unstructured":"Barthelemy NR, Salvado G, Schindler SE, He Y, Janelidze S, Collij LE, et al. Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests. Nat Med. 2024;30(4):1085\u201395.","journal-title":"Nat Med"},{"issue":"4","key":"789_CR20","doi-asserted-by":"publisher","first-page":"e228392","DOI":"10.1001\/jamanetworkopen.2022.8392","volume":"5","author":"Y Hu","year":"2022","unstructured":"Hu Y, Kirmess KM, Meyer MR, Rabinovici GD, Gatsonis C, Siegel BA, et al. Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment. JAMA Netw Open. 2022;5(4):e228392.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"789_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/alz.13542","volume":"20","author":"RA Rissman","year":"2024","unstructured":"Rissman RA, Langford O, Raman R, Donohue MC, Abdel-Latif S, Meyer MR, et al. Plasma Abeta42\/Abeta40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(2):1214\u201324.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"789_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, et al. The Alzheimer\u2019s disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging: Official J Int Soc Magn Reson Med. 2008;27(4):685\u201391.","journal-title":"J Magn Reson Imaging: Official J Int Soc Magn Reson Med"},{"issue":"3","key":"789_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr., Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(3):205\u201316.","journal-title":"Alzheimers Dement"},{"issue":"20","key":"789_CR24","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","volume":"78","author":"DS Knopman","year":"2012","unstructured":"Knopman DS, Jack CR Jr., Wiste HJ, Weigand SD, Vemuri P, Lowe V, et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology. 2012;78(20):1576\u201382.","journal-title":"Neurology"},{"key":"789_CR25","doi-asserted-by":"crossref","unstructured":"Zeltzer E, Schonhaut DR, Mundada NS, Blazhenets G, Soleimani-Meigooni DN, Cho H, et al. Concordance between amyloid-PET quantification and real-world visual reads. JAMA Neurol. 2025.","DOI":"10.1101\/2024.10.31.24316518"},{"issue":"1","key":"789_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43\u20136.","journal-title":"Epidemiology"},{"issue":"7139","key":"789_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","volume":"316","author":"TV Perneger","year":"1998","unstructured":"Perneger TV. What\u2019s wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236\u20138.","journal-title":"BMJ"},{"issue":"1","key":"789_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12987-023-00455-y","volume":"20","author":"A Jeppsson","year":"2023","unstructured":"Jeppsson A, Sandelius A, Zettergren A, Kern S, Skoog I, Blennow K, et al. Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus. Fluids Barriers CNS. 2023;20(1):54.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"789_CR29","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41467-025-57144-7","volume":"16","author":"S Abu-Rumeileh","year":"2025","unstructured":"Abu-Rumeileh S, Scholle L, Mensch A, Grosskopf H, Ratti A, Kolsch A, et al. Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis. Nat Commun. 2025;16(1):2019.","journal-title":"Nat Commun"},{"issue":"7","key":"789_CR30","doi-asserted-by":"publisher","first-page":"e213438","DOI":"10.1212\/WNL.0000000000213438","volume":"104","author":"E Sanchez","year":"2025","unstructured":"Sanchez E, Coughlan GT, Wilkinson T, Ramirez J, Mirza SS, Baril AA, et al. Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases. Neurology. 2025;104(7):e213438.","journal-title":"Neurology"},{"key":"789_CR31","doi-asserted-by":"crossref","unstructured":"Bermudez C, Syrjanen JA, Stricker NH, Algeciras-Schimnich A, Kouri N, Kremers WK, et al. Impact of cardiovascular risk factors on plasma biomarkers in prediction of Alzheimer\u2019s and cerebrovascular neuropathology. J Prev Alzheimers Dis. 2025:100224.","DOI":"10.1016\/j.tjpad.2025.100224"},{"issue":"8","key":"789_CR32","doi-asserted-by":"publisher","first-page":"e70562","DOI":"10.1002\/alz.70562","volume":"21","author":"L Montoliu-Gaya","year":"2025","unstructured":"Montoliu-Gaya L, Valeriano-Lorenzo E, Ashton NJ, Lopez-Gonzalez FJ, Lantero-Rodriguez J, Ruiz-Gonzalez A, et al. Plasma tau biomarkers are distinctly associated with tau tangles and decreased with Lewy body pathology. Alzheimers Dement. 2025;21(8):e70562.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"789_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","volume":"80","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Barthelemy NR, He Y, Bateman RJ, Hansson O. Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios. JAMA Neurol. 2023;80(5):516\u201322.","journal-title":"JAMA Neurol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00789-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:43:44Z","timestamp":1776077024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00789-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00789-3","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Mayo Clinic Institutional Review Board and the Olmsted Medical Center Institutional Review Board. All procedures were conducted in accordance with the Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"PMC has received honoraria from Eisai. She serves on DSMB for Eisai and Lilly but receives no compensation to self or institution. BDE: Consultant for Amgen, SI Bone, Depuy Synthes, Iota Biosciences; Clinical Trial Funding from SI Bone, Stryker, and Medimaps; Royalty agreement with SI Bone and Elsevier; Stock in Injectsense; Medical Advisory Board for Injectsense. AA-S has participated in advisory boards for Roche Diagnostics, Fujirebio Diagnostics and Siemens Healthineers, and has received speaker honoraria from Roche Diagnostics and Eli Lilly. JGR is in the DSMB for NINDS strokeNET. He is also a site investigator for trials sponsored by Eisai and Cognition therapeutics. CGS receives research funding from the NIH. VL serves as a consultant for Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, Eli Lilly and Company, PeerView Institute for Medical Education, and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals, and the NIH (NIA, NCI). MMM has served on scientific advisory boards and\/or has consulted for Acadia, Althira, Biogen, Cognito Therapeutics, Eisai, Lilly, Merck, Novo Nordisk, Neurogen Biomarking, and Roche; received speaking honorariums from Novo Nordisk, PeerView Institute, and Roche; and receives grant support from the National Institute of Health, Department of Defense, Alzheimer\u2019s Association, and Davos Alzheimer\u2019s Collaborative. CRJ receives no compensation from any commercial entity. He receives research support from NIH, the GHR Foundation, and the Alexander Family Alzheimer\u2019s Disease Research Professorship of the Mayo Clinic.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}